The Toll like receptor 4 ligand cold-inducible RNA-binding protein as vaccination platform against cancer

The Toll like receptor 4 ligand cold-inducible RNA-binding protein as vaccination platform against cancer

Tumor infiltrating lymphocytes have been associated with a better prognostic and with higher response rates in patients treated with checkpoint inhibiting antibodies, suggesting that strategies promoting tumor inflammation may enhance the efficacy of these currently available therapies. Our aim was...

Full description

Bibliographic Details
Main Authors: Lorea Villanueva, Leyre Silva, Diana Llopiz, Marta Ruiz, Tamara Iglesias, Teresa Lozano, Noelia Casares, Sandra Hervas-Stubbs, María José Rodríguez, José L. Carrascosa, Juan José Lasarte, Pablo Sarobe
Format: Article
Language:English
Published: Taylor & Francis Group 2018-04-01
Series:OncoImmunology
Subjects:
checkpoint inhibitor
dendritic cells
targeting
therapeutic vaccination
tlr4 ligand
Online Access:http://dx.doi.org/10.1080/2162402X.2017.1409321

Internet

http://dx.doi.org/10.1080/2162402X.2017.1409321

Similar Items